Insulin as a vascular hormone: Implications for the pathophysiology of cardiovascular disease

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 3-4, 1998, Pages 175-184

  Cleland, Stephen J ^a,b   Pétrie, John R ^a   Ueda, Shinichiro ^a   Elliott, Henry L ^a   Connell, John Mc ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Blood flow; Cardiovascular risk; Endothelial function; Insulin sensitivity

Indexed keywords

INSULIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CONGESTIVE HEART FAILURE; ESSENTIAL HYPERTENSION; GLUCOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; LIMB BLOOD FLOW; METABOLIC DISORDER; MUSCLE BLOOD FLOW; OBESITY; PATHOPHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0031976515     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.t01-15-.x     Document Type: Review

References (122)

1. De Fronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
2. Yki-Jarvinen H, Koivisto VA. Effect of body composition on insulin sensitivity. Diabetes 1983; 32: 965-9.
3. De Fronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: A balanced overview. Diabetes Care 1992; 15: 316-68.
4. Ferrannini E, Buzzigoli G, Bonadonna R et al. Insulin resistance in essential hypertension. N. Engl. J. Med. 1987; 317: 350-7.
5. Swan JW, Wallon C, Godsland IF, Clark AL, Coats AJS, Oliver MF, Insulin resistance in chronic heart failure. Eur. Heart J. 1994; 15: 1528-32.
6. Williams SB, Cusco JA, Roddy M, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with noninsulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 1996; 27: 567-74.
7. Calver A, Collier J, Moncada S, Vallance P. Effect of local intraarterial M'-monomethyl-L-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal. J. Hypertens. 1992; 10: 1025-31.
8. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-74.
9. Drexler H, Hayoz D, Munzel T et al. Endothelial function in chronic heart failure. Am. J. Cardiol. 1993; 126: 761.
10. Natali A, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 1991; 17: 170-8.
11. Baron A. Hemodynamic actions of insulin. Am. J. Physiol. 1994; 267: El 87-202.
12. lannaccone ST, Li K, Sperelakis N, Lathrop DA. Insulin-induced hyperpolarization in mammalian skeletal muscle. Am. J. Physiol. 1989; 256: C368-74.
13. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: A novel mechanism for insulin resistance. J. Clin. Invest. 1990; 85: 1844-52.
14. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 1994; 94: 2511-15.
15. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 1991; 87: 2246-52.
16. Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulinmediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992; 41: 1076-83.
17. Edelman SV, Brechtel G, Wallace P, Baron A. Role of plasma flow to determine rates of m vivo insulin-mediated glucose uptake. Clin. Res. 1988:36: 151A (Abstract).
18. Bennett NW, Connacher AA, Scrimgeour CM, Jung RT, Rennie MJ. Euglycaemic hyperinsulinaemia augments amino acid uptake by human tissue during hyperaminoacidaemia. Am. J. Physiol. 1990; 259: El 85-94.
19. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J. Clin. Invest. 1994; 93: 2365-71.
20. Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995; 38: 555-64.
21. Capaldo B, Lembo G, Napoli R et al. Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 1991; 40: 1320-2.
22. Defronzo RA, Gunnarson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 1985; 76: 149-55.
23. Natali A, Bonadonna R, Santoro D et al. Insulin resistance and vasodilation in essential hypertension: Studies with adenosine. J. Clin. Invest. 1994; 94: 1570-6.
24. Yki-Jarvinen H, Young AA, Lamkin C, Foley JE. Kinetics of glucose disposal in whole body and across the forearm in man. J. Clin. Invest. 1987; 79: 1713-19.
25. Nuutila P, Raitakari M, Laine H et al. Role of blood flow in regulating insulin-stimulated glucose uptake in humans: Studies using bradykinin, [I5O]water, and [18F]fluoro-deoxy-gIucose and positron emission tomography./ Clin. Invest. 1996; 97: 1741-7.
26. Pendergrass M, Fazioni E, Cruz J, Collins D, DeFronzo RA. Local, but not systemic insulin infusion stimulates forearm blood flow. Diabetes 1996; 45 (Suppl. 2): 1205A.
27. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634-40.
28. Muntzel M, Beltz T, Mark AL, Johnson AK. Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin. Hypertension 1994; 23: 1059-62.
29. Mathias CI, daCosta DF, Fosbraey P, Christesen NJ, Bunmister R. Hypotensive and sedative effects of insulin in autonomie failure. BMJ 1987; 295: 161-3.
30. Lembo G, laccarino G, Vecchioe C, Rendina V, Parrella L, Trimarco B. Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. Circulation 1996; 93: 1403-10.
31. Sakai K, Imaizumi T, Masaki H, Takeshita A. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension 1993; 22: 67-73.
32. Lembo G, laccarino G, Rendina V, Volpe M, Trimarco B. Insulin blunts sympathetic vasoconstriction through the ot2-adrenergic pathway in humans. Hypertension 1994; 24: 429-38.
33. Randin D, Vollenweider P, Tappy L, Jequier E, Nicod P, Scherrer U. Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am. J. Physiol. 1994; 266: R809-16.
34. Anderson EA, Hoffman RP, Balon TVV, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 1991; 87: 2246-52.
35. Sartori C, Trueb L, Sherrer U. Insulin's direct vasodilator action in humans is masked by sympathetic vasoconstrictor tone. Diabetes 1996; 45 (Suppl. 2): 309A.
36. Creager MA, Liang C, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J. Pharmacol. Exp. Ther. 1985; 235: 709-14.
37. Natali A, Buzzigoli G, Taddi S et al. Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes 1990; 39: 490-500.
38. Chisholm DJ, Klassen GA, Dupre J, Pozefsky T. Interaction of secretin and insulin on human forearm metabolism. Eur. J. Clin. Invest. 1975; 5:487-94.
39. Gelfand RA, Barrett EJ. Effect of physiological hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J. Clin. Invest. 1987; 80: 1-6.
40. Andres R, Baltzan MA, Cader G, Zierler KL. Effect of insulin on carbohydrate metabolism and on potassium in the forearm of man. J. Clin. Invest. 1961; 41: 108-15.
41. Neahring JM, Stepniakowski K, Greene AS, Egan BM. Insulin does not reduce forearm a-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension 1993; 22: 584-90.
42. Ueda S, Pétrie JR, Elliott HL, Connell JMC. Insulin-mediated vasodilatation is dependent on local glucose concentrations. Hypertension 1995; 26: 561 (Abstract).
43. Baron AD. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillieres Clin. Endocrinol. Metab. 1993; 7: 961-87.
44. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide depen-dent: A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 1994; 94: 1172-9.
45. Cleland SJ, Pétrie JR, Ueda S, Elliott HL, Connell JMC. Insulin vasodilatation is abolished by both L-NMMA and angiotensin II. J. Hypertens. 1997; 15 (Suppl. 4): S71 (Abstract).
46. Tack CJ, Lutterman JA, Vervoort G, Thien T, Smits P. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension 1996; 28: 426-32.
47. Pete G, Hu Y, Walsh M, Sowers J, Dunbar JC. Insulin-like growth factor-1 decreases mean blood pressure and selectively increases regional blood flow in normal rats. P roc. Soc. Exp. Biol. Med. 1996; 213: 187-92.
48. Haylor J, Singh I, El-Nahas AM. Nitric oxide synthesis inhibitor prevents vasodilation by insulin like growth factor 1. Kidney Int. 1991; 39: 333-5.
49. Wu H-Y, Young YJ, Yue C-J, Kuang-Yuh C, Hsueh WA, Chan TM. Endothelial-dependent vascular effects of insulin and insulin-like growth factor-1 in the perfused rat mesenteric artery and aortic ring. Diabetes 1994; 43: 1027-32.
50. McKay MK, Hester RL. Role of nitric oxide, adenosine, and ATPsensitive potassium channels in insulin-induced vasodilation. Hypertension 1996; 28: 202-8.
51. Ueda S, Pétrie JR, Elliott HL, Connell JMC. L-Arginine potentiates the vasodilating action of insulin in the human forearm. J. Hypertens. 1996; 14 (Suppl. 1): S164 (Abstract).
52. Sobrevia L, Nadal A, Yudilevich DL, Mann GE. Activation of L-arginine transport (system y) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J. Pliysiol. 1996; 490: 775-81.
53. Han S, Ouchi Y, Karaki H, Orimo H. Inhibitory effects of insulin on cytosolic Ca2level and contraction in the rat aorta: Endotheliumdependent and -independent mechanisms. Circ. Res. 1995; 77: 673-8.
54. Thorn S, Hughes A, Sever PS. Endothelium-dependent responses in human arteries. In: Vanhoutte PM (ed.). Relaxing and Contracting Factors. Humana Press Inc., Clifton. 1988; 511-28.
55. Meharg JV, McGowan-Jordan J, Charles A, Parmelee JT, Cutaia MV, Rounds S. Hydrogen peroxide stimulates sodium-potassium pump activity in cultured pulmonary arterial endothelial cells. Am. J. Physiol. 1993; 265: L613-21.
56. Elliott SJ, Schilling WP. Oxidant stress alters Na+-pump and Na-K-Cl~ cotransporter activities in vascular endothelial cells. Am. J. Physiol. 1992; 263: H96-102.
57. Luckhoff A, Busse R. Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Schmiedebergs Arch. Phannacol. 1990; 342: 94-9.
58. Kahn AM, Seidel CL, Allen JC, O'Neil RG, Shelat H, Song T. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 1993; 22: 735-42.
59. Baldi S, Natali A, Buzzigoli G, Galvan AQ, Sironi AM, Ferrannini E. In vivo effect of insulin on intracellular calcium concentrations: Relation to insulin resistance. Metabolism 1996; 45: 1402-7.
60. Zemel MB, Johnson BA, Ambrozy SA. Insulin stimulated vascular relaxation: role of Ca2+-ATPase. Am. J. Hypertens. 1992; 5: 637-41.
61. Pontrememali R, Rivera A, Canessa M. Insulin and cytosolic Ca(Cai) modulate the human red cell Na/H exchanger (EXC). Clin. Res. 1991; 39: 192A (Abstract).
62. Clausen T. Regulation of active Na-K+ transport in skeletal muscle. Physiol. Rev. 1986; 66: 542-80.
63. Rosic K, Standaert ML, Pollet RJ. The mechanism of insulin stimulation of (Na+,Kt)-ATPase transport activity in muscle. Biol. Chem. 1985; 260: 6206-12.
64. Touyz RM, Tolloczko B, Schiffrin EL. Insulin attenuates agonistevoked calcium transients in vascular smooth muscle cells. Hypertension 1994; 23 (Suppl. I): 123-8.
65. Baron AD, Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G. Insulin-mediated skeletal muscle vasodilation con-tributes to both insulin sensitivity and responsiveness in lean humans. J. Clin. Invest. 1995; 96: 786-92.
66. Feldman RD, Hramiak IM, Finegood DT, Behme MT. Parallel regulation of the local vascular and systemic metabolic effects of insulin. J. Clin. Endocrinol. Metab. 1995; 80: 1556-9.
67. Pétrie J, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity: A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996; 93: 1331-3.
68. Utriainen TR, Makimattila S, Virkamaki A, Bergholm R, YkiJarvinen H. Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects. Diabetologia 1996; 39: 1477-82.
69. Mijares AH, Jensen MD. Contribution of blood flow to leg glucose uptake during a mixed meal. Diabetes 1995; 44: 1165-9.
70. Kelly D, Mitrakou A, Marsh H et al. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J. Clin. Invest. 1988; 81: 1563-71.
71. Vollenweider P, Tappy L, Randin D et al. Differential effects of hyperinsulinaemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J. Clin. Invest. 1993; 92: 147-54.
72. Baron AD, Laakso M, Brechtel G, Edelman SV. Mechanisms of insulin resistance in insulin-dependent diabetes mellitus: A major role for reduced skeletal muscle blood flow. J. Clin. Endocrinol. Metab. 1991; 73: 637-13.
73. Delà F, Larsen JJ, Mikines KJ, Galbo H. Normal effect of insulin to stimulate leg blood flow in NIDDM. Diabetes 1995; 44: 221-6.
74. Yki-Jarvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 1995; 38: 1378-88.
75. Dietze GJ, Wicklmayr M, Rett K, Jacob S, Henriksen FJ. Potential role of bradykinin in forearm muscle metabolism in humans. Diabetes 1996; 45 (Suppl. 1): S110-14.
76. Kohlman O, Neves F, Ginoza M et al. Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinaemia. J. Hypertens. 1995; 25: 1003-7.
77. Clark MG, Colquhoun EQ, Rattigan S et al. Vascular and endocrine control of muscle metabolism. Am. J. Physiol. 1995; 268: E797-812.
78. Ahn YI, Ferrel RE, Hamman RF, Kamboh MI. Association of lipoprotein lipase gene variation with the physiological components of the insulin resistance syndrome. Diabetes Care 1993; 16: 1502-5.
79. Yang YJ, Hope ID, Ader M, Bergman RN. Insulin transport across capillaries is rate limiting for insulin action in dogs. J. Clin. Invest. 1989; 84: 1620-8.
80. Haffner SM, Ferrannini E, Hazuda HP, Stem MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992; 9: 983-6.
81. Salomaa W, Strandberg TE, Vanhanen H, Naukkarinen V, Sarna S, Miettinen TA. Glucose tolerance and blood pressure: Long term follow up in middle aged men. BMJ 1991; 302: 493-6.
82. Despres JP, Lamarche B, Mauriege P et al. Hyperinsulinaemia as an independent risk factor for ischaemic heart disease. N. Engl. J. Med. 1996; 334: 952-7.
83. Morris AD, Pétrie JR, Connell JMC. Insulin and hypertension. J. Hypertens. 1994; 12: 633-12.
84. Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive parents. BMJ 1993; 307:92-6.
85. Endre T, Mattiasson I, Lennart Hulthen U, Lindgarde F, Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J. Hypertens. 1994; 12: 81-8.
86. Lennart Hulthen U, Endre T, Mattiasson I, Berglund G. Insulin and forearm vasodilation in hypertension-prone men. Hypertension 1995; 25: 214-18.
87. Nyholm B, Mengel A, Nielsen S et al. Insulin resistance in relatives of NIDDM patients: The role of physical fitness and muscle metabolism. Diabetologia 1996; 39: 813-22.
88. Reaven GM, Chen YI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinaemia in individuals with small density low density lipoprotein particles. J. Clin. Invest. 1993; 92: 141-6.
89. DiCorleto PE, Soyombo AA. The role of the endothelium in atherogenesis. Curr. Opin. Lipidol. 1993; 4: 364-72.
90. Graier \VF, Wascher TC, Lackener L, Tplak H, Krejs GJ, Kukovetz WR. Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes 1993; 42: 1497-505.
91. Kahn AM, Lichtenberg RA, Allen JC, Seidel CL, Song T. Insulinstimulated glucose transport inhibits Ca2 influx and contraction in vascular smooth muscle. Circulation 1995; 92: 1597-603.
92. Wu G, Majumdar S, Zhang J, Lee H, Meinenger CJ. Insulin stimulates glycolysis and pentose cycle activity in bovine microvascular endothelial cells. Comp. Biochem. Physio!. 1994; 108A: 179-85.
93. Rosetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610-30.
94. Richter EA, Hansen BF, Hansen SA. Glucose-induced insulin resistance of skeletal-muscle glucose transport and uptake. Biochem. J. 1988; 252: 733-7.
95. Poston L, Taylor PD. Endothelial-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sei. 1995; 88: 245-55.
96. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988; 318 (Suppl. 20): 1315-21.
97. Simoneau JA, Bouchard C. Skeletal muscle metabolism in normal weight and obese men and women. Int. J. Obesity 1993; 17 (Suppl. 2): 31-6.
98. Wade AJ, Marbut MM, Round JM. Muscle fibre type and aetiology of obesity. Lancet 1990; 335: 805-8.
99. Lillioja S, Young AA, Culler CL et al. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J. Clin. Invest. 1987; 80:415-24.
100. Krotkiewski M, Bjomtorp P. Muscle tissue in obesity with different distribution of adipose tissue: Effects of physical training. Int. J. Obesity 1986; 10: 331-41.
101. Frisk-Holmberg M, Essen B, Fredrikson M, Strom G, Wibell L. Muscle fibre composition in relation to blood pressure response to isometric exercise in normotensive and hypertensive subjects. Acta Med. Scand. 1983; 213: 21-6.
102. Juhlin-Dannfelt A, Frisk-Holmberg F, Karlson J, Tesch P. Central and peripheral circulation in relation to muscle fibre composition in normo- and hypertensive man. Clin. Sei. 1979; 56: 335-10.
103. Frisk-Holmberg M, Jorfeldt L, Juhlin-Dannfelt A, Karlsson J. Leg blood flow during exercise in man in relation to muscle fibre composition. Acta Physiol. Scand. 1981; 112: 339-42.
104. Andersen P, Henriksson J. Training-induced changes in subgroups of human type II skeletal muscle fibers. Acta Physiol. Scand. 1977; 99: 123-5.
105. Andersen P. Capillary density in skeletal muscle of man. Acta Physiol. Scand. 1975; 95: 203-5.
106. Andersen P, Henriksson J. Capillary supply of quadriceps femoris muscle of man: Adaptive response to exercise. J. Physiol. 1977; 270: 677-90.
107. Krotkiewski M, Bylund-Fallenius AC, Holm J, Bjomtorp P, Grimby G, Mandroukas K. Relationship between muscle morphology and metabolism in obese women: The effects of long-term physical training. Eur. J. din. Invest. 1983; 13: 5-12.
108. Paffenbarger RS Jr, Wing AL, Hyde RT, Jung DL. Physical activity and incidence of hypertension in college alumni. Am. J. Epidemiol. 1983; 117: 245-57.
109. Tipton CM. Exercise, training and hypertension: An update. Exer. Sports Sei. Rev. 1991; 19:447-505.
110. Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, Ehsani A A. Effects of exercise on glucose tolerance and insulin resistance. Acta Med. Scand. Suppl. 1987; 711: 55-65.
111. Shimoketa H, Muller DC, Fleg JL, Soctrin J, Ziemba AW, Andres R. Age as independent determinant of glucose tolerance. Diabetes 1991; 40:44-51.
112. Komi PV, Karlsson J. Physical performance, skeletal muscle enzyme activities and fiber types in monozygous twins. Acta Med. Scand. 1979; 422 (Suppl.): 1-28.
113. Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive parents. BMJ 1993; 307: 92-£.
114. Jarrett RJ. In defence of insulin: A critique of syndrome X. Lancet 1992; 340: 469-71.
115. Pétrie JR, Donnelly R. New pharmacological approaches to insulin and lipid metabolism. Drugs 1994; 47: 701-10.
116. Holmang A, Bjorntorp P. The effects of cortisol on insulin sensitivity in muscle. Acta Physiol. Scand. 1992; 144:425-31.
117. Walker BR, Swan PJH, Ohin P et al. Mechanisms of glucocorticoidinduced hypertension: Inhibition of endothelium-dependent vasodila-lion in rat and human vessels. J. Etidocrinol. 1995; 144 (Suppl.): OC34 (Abstract).
118. Holmang A, Jennische E, Bjorntorp P. Rapid formation of capillary endothelial cells in rat skeletal muscle after exposure to insulin. Diabetologia 1996; 39: 206-11.
119. Scherrer U, Vollenweider P, Randin D, Jequier E, Nicod P, Tappy L. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 1993; 88: 388-94.
120. Rebuffe-Scrive M, Krotkiewski M, Elverson J, Bjomthorp P. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J. Clin. Endocrinol. Melab. 1988; 67: 1122-5.
121. Walker BR, Best R, Shackleton CHL, Padfield PL, Edwards CRW. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 1996; 27: 190-6.
122. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 1997; 349: 1210-13.